Chronic Obstructive
Pulmonary Disease Treatment Market: Introduction
Transparency Market Research has published a new report
on the chronic obstructive pulmonary disease (COPD) treatment
market
Chronic obstructive pulmonary disease is a group of
conditions affecting the lungs, which leads to difficulty in breathing. Chronic
bronchitis and emphysema are two major indications included under chronic
obstructive pulmonary disease (COPD). Breathlessness is a major characteristic
of COPD. In case of emphysema, the alveoli (tiny air sacs) in the lungs are
damaged. The walls of the alveoli are stretched, making the lungs bigger,
resulting in difficulty in the movement of air. In chronic bronchitis, the
bronchial airways (breathing tubes) inside the lungs are inflamed.
In terms of drug class, the combination therapy segment
of the chronic obstructive pulmonary disease treatment market held a major
share of the global COPD treatment market in 2018. It is likely to
maintain its dominance in the chronic obstructive pulmonary disease treatment
market during the forecast period, owing to its increased efficacy for COPD
treatment. Based on distribution channel, the retail pharmacies segment of the
COPD treatment market is estimated to account for a major share of the market.
This segment of the chronic obstructive pulmonary disease treatment market is
anticipated to expand at a rapid pace during the forecast period, owing to an
increase in the number of COPD therapeutics being dispensed through retail
pharmacies, and rise in the number of retail pharmacies in developing
countries. Chronic obstructive pulmonary disease is characterized by
progressive airflow limitation not fully reversible, and is a major cause of
morbidity and mortality, worldwide. However, patent expiry of branded products
and availability of generic equivalents and alternative treatment options are
factors that are expected to hamper the growth of the global COPD treatment
market during the forecast period.
Request for
Analysis of COVID19 Impact on Chronic Obstructive Pulmonary Disease Treatment
Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=73763
Global Chronic
Obstructive Pulmonary Disease Treatment Market: Prominent Regions
North America held a major share of the global chronic
obstructive pulmonary disease treatment market. The COPD treatment market in
the region is primarily driven by factors such as highly structured healthcare
industry and availability of well-defined reimbursement policies from private
and public health insurance firms. In addition, extensive research and
development to provide advanced and efficient products, and a large number of
players in the region, are factors driving the chronic obstructive pulmonary
disease treatment market in North America. The chronic obstructive pulmonary
disease market in Asia Pacific is estimated to witness significant growth. Asia
Pacific is a relatively untapped COPD treatment market as compared to developed
regions. Hence, the region offers immense growth opportunities to market
players. Factors such as high prevalence of chronic obstructive pulmonary
disease, rise in geriatric population, surge in patient population, and growth
of the healthcare industry are fueling the expansion of the COPD treatment
market in the region.
Europe held the second-largest share of the global
chronic obstructive pulmonary disease treatment market in 2018.
Well-developed healthcare infrastructure and increase in the number of
incidences of chronic obstructive pulmonary disease are driving the COPD
treatment market in the region. The chronic obstructive pulmonary disease
treatment markets in the Middle East & Africa and Latin America are
projected to witness moderate growth in the near future.
Purchase
Chronic Obstructive Pulmonary Disease Treatment Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=73763<ype=S
Chronic Obstructive
Pulmonary Disease Treatment Market: Key Players
Key players are expanding their footprint to strengthen
their position in the global chronic obstructive pulmonary disease treatment
market. Emerging economies, due to increase in the number of patient
population, and rise in tobacco smoking and air population, offer lucrative
opportunities to key players to increase their market share. Manufacturers are
engaging in new product development, collaborations, acquisitions, and
distribution agreements. For instance, in July 2018, Orion
Corporation signed a multi-year licensing agreement with Menarini to distribute
and commercialize the former’s Easyhaler products. According to the agreement,
Menarini would be supplying Orion’s products in Asia Pacific countries such as
China, the Philippines, Malaysia, Hong Kong, Indonesia, Vietnam, Thailand,
Singapore, South Korea, and Taiwan.
Prominent players operating in the global chronic
obstructive pulmonary disease treatment market are AstraZeneca,
Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Novartis AG, Teva
Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals Inc. (Sumitomo
Dainippon Pharma Co., Ltd.), CHIESI Farmaceutici S.p.A., Orion Corporation, and
Mylan N.V.
More Trending Reports by
Transparency Market Research:
About Us
Transparency Market Research is a global market
intelligence company, providing global business information reports and
services. Our exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers. Our
experienced team of analysts, researchers, and consultants use proprietary data
sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised
by a team of research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability, Transparency Market
Research employs rigorous primary and secondary research techniques in
developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
